BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9260476)

  • 1. Chronic systemic aspergillosis.
    Rüchel R; Kern W
    Mycoses; 1997; 40(1-2):1. PubMed ID: 9260476
    [No Abstract]   [Full Text] [Related]  

  • 2. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Prince RA; Chi J; Kontoyiannis DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
    Moore L; Ellis DH; Suppiah R; Byard RW; Toogood IR
    J Paediatr Child Health; 1993 Apr; 29(2):141-3. PubMed ID: 8387801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
    Sarcía-Ruiz JC; Alvarez C; Floristán F; Hernández I; Hernández J; Alvarez Blanco A; Ponton J
    Sangre (Barc); 1993 Oct; 38(5):399-402. PubMed ID: 8140504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
    Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
    J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of pulmonary aspergillosis successfully treated with itraconazole].
    Watanabe T; Kuriyama K; Kamei K
    Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
    [No Abstract]   [Full Text] [Related]  

  • 8. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
    Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
    Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B.
    Burton JR; Zachery JB; Bessin R; Rathbun HK; Greenough WB; Sterioff S; Wright JR; Slavin RE; Williams GM
    Ann Intern Med; 1972 Sep; 77(3):383-8. PubMed ID: 4559787
    [No Abstract]   [Full Text] [Related]  

  • 10. Complicated pulmonary aspergillosis with pneumothorax and pneumopericardium in a child with acute lymphoblastic leukemia.
    Merino JM; Díaz MA; Ramírez M; Ruano D; Madero L
    Pediatr Hematol Oncol; 1995; 12(2):195-9. PubMed ID: 7626390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopenia.
    Buchheidt D; Hummel M; Diehl S; Hehlmann R
    Eur J Haematol; 2004 May; 72(5):375-6. PubMed ID: 15059076
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia.
    Ng A; Gadong N; Kelsey A; Denning DW; Leggate J; Eden OB
    Pediatr Hematol Oncol; 2000 Sep; 17(6):497-504. PubMed ID: 10989471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH56592 treatment of murine invasive aspergillosis.
    Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
    J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
    Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
    Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis. Report of a case.
    Salmassi S; Anwar A; Salem T; Zarabi CM; Reisz G
    Mo Med; 1986 Sep; 83(9):626-30. PubMed ID: 3334074
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
    Trigg ME; Menezes AH; Giller R; Lanza L; Smith RJ; Sato Y; Peters C; Altman A
    Bone Marrow Transplant; 1993 Jun; 11(6):493-6. PubMed ID: 8392887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birefringent crystals in a lung cavity.
    Harigopal P; Bejarano P; Burke G; Dowdy LM
    Clin Infect Dis; 2005 Jun; 40(12):1806, 1849-50. PubMed ID: 15912600
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.